Cargando…
Endocannabinoids in Alzheimer's disease and their impact on normative cognitive performance: a case-control and cohort study
BACKGROUND: Neuropathological, animal, and cell culture studies point to a role for the body's own endogenous cannabinoids (eCBs) system in Alzheimer's disease (AD) pathology and treatment. To date, no published studies have investigated the potential utility of circulating eCBs as diagnos...
Autores principales: | Koppel, Jeremy, Bradshaw, Heather, Goldberg, Terry E, Khalili, Houman, Marambaud, Philippe, Walker, Michael J, Pazos, Mauricio, Gordon, Marc L, Christen, Erica, Davies, Peter |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2631501/ https://www.ncbi.nlm.nih.gov/pubmed/19144193 http://dx.doi.org/10.1186/1476-511X-8-2 |
Ejemplares similares
-
An Open-Label Exploratory Study with Memantine: Correlation between Proton Magnetic Resonance Spectroscopy and Cognition in Patients with Mild to Moderate Alzheimer's Disease
por: Gordon, Marc L., et al.
Publicado: (2012) -
Haloperidol inactivates AMPK and reduces tau phosphorylation in a tau mouse model of Alzheimer's disease
por: Koppel, Jeremy, et al.
Publicado: (2016) -
Anesthesia promotes acute expression of genes related to Alzheimer’s disease and latent tau aggregation in transgenic mouse models of tauopathy
por: Eun, John David, et al.
Publicado: (2022) -
Endocannabinoids and Reproduction
por: Meccariello, Rosaria, et al.
Publicado: (2014) -
Therapeutic potential of resveratrol in Alzheimer's disease
por: Vingtdeux, Valérie, et al.
Publicado: (2008)